Mohammed Masri MD in Mount Clemens, Michigan

Home Michigan Mount Clemens

Mohammed Masri MD has Hematology/oncology as his primary medical specialty. Their primary office is: 1080 Harrington St in Mount Clemens, Michigan. There is an additional office location, for a total of two, for Mohammed Masri MD that can be viewed further down.

They're a part of the: Mclaren Oakland medical group which has around 49 members. You can call their office at 586-493-3440 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Minnesota Medical School and graduated in 1998 (around 26 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Mohammed T Masri MD Office Phone and Directions

Mohammed Masri MD
Mclaren Oakland
1080 Harrington St
Mount Clemens, Michigan 48043
586-493-3440

Patient Ratings
Please rate your experience with Mohammed Masri MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 586-493-3440

Enter a starting address:

Healthcare Info for Mohammed Masri MD

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: University Of Minnesota Medical School
Graduation Year: 1998
The Primary Medical Specialty for Mohammed Masri MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 26
PAC (PECOS ID)#: 4688664436
NPI #: 1669409439
NPI Created On: 06/27/2006
NPI Last Updated Listed as: 11/15/2023
Primary Taxonomy Code: 207RH0003X
License Number:
4301106637
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Medica Insurance Company
Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Arabic.

Services and Procedures include:

New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788538423

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 790254307

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: Rubraca

Open Associated Drug #1: 69660-201-91

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818592137

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818613153

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $110

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818666921

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832153823

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832153875

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832153941

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835954599

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: Alecensa

Open Associated Drug #1: 50242-130-01

Drug or Biological: Biological

Product Category #2: BioOncology

Name Of Drug #2:: TECENTRIQ

Associated Drug #2: 50242-917-01

Drug or Biological #3:: Biological

Product Category #3: BioOncology

Name of Drug: ROZLYTREK

Name Of Drug #3: 50242-091-30

Drug or Biological: Drug

Product Category #4: BioOncology

Name of Drug #4: GAVRETO

Associated Drug #4: 50242-210-60

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835954602

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: GAZYVA

Open Associated Drug #1: 50242-070-01

Drug or Biological: Biological

Product Category #2: BioOncology

Name Of Drug #2:: POLIVY

Associated Drug #2: 50242-105-01

Additional Office Locations

1. Mclaren Oakland
5680 Bow Pointe Dr
Clarkston, MI 48346
Suite 202
Group Members: 49

Phone: 586-493-3440

Enter a starting address:

Hematology/oncology Professionals in Mount Clemens

1.
Frank Knechtl DO

1080 Harrington St
Mount-clemens, MI
Mclaren Oakland

2.
Rana Bilbeisi

1080 Harrington St
Mount-clemens, MI
Mclaren Oakland

Providers in Mclaren Oakland

1.Fadi Alkhankan

50 N Perry St
Pontiac Mi 48342-2217
Mclaren Oakland
Pulmonary Disease

2.Robert Basak

385 N Lapeer Rd
Oxford Mi 48371-3610
Mclaren Oakland
Family Practice

3.Sai Bikkina

50 N Perry St
Pontiac Mi 48342-2217
Mclaren Oakland
Hematology/oncology

4.Sai Bikkina

1295 Barry Dr
Lapeer Mi 48446-1369
Mclaren Oakland
Hematology/oncology

5.Sai Bikkina

43097 Woodward Ave
Bloomfield Hills Mi 48302-5042
Mclaren Oakland
Hematology/oncology

6.Rana Bilbeisi

1080 Harrington St
Mount Clemens Mi 48043-2903
Mclaren Oakland
Hematology/oncology

View all 49 members of Mclaren Oakland medical group